Emami (531162) Panoramica del titolo
Emami Limited produce e commercializza prodotti per la cura della persona e della salute in India e a livello internazionale. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 3/6 |
| Crescita futura | 2/6 |
| Prestazioni passate | 3/6 |
| Salute finanziaria | 6/6 |
| Dividendi | 6/6 |
Premi
Analisi del rischio
Non sono stati rilevati rischi per 531162 dai nostri controlli di rischio.
531162 Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di Emami Limited
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | ₹394.20 |
| Massimo di 52 settimane | ₹634.65 |
| Minimo di 52 settimane | ₹376.05 |
| Beta | 0.15 |
| Variazione di 1 mese | -11.55% |
| Variazione a 3 mesi | -7.91% |
| Variazione di 1 anno | -33.33% |
| Variazione a 3 anni | 3.93% |
| Variazione a 5 anni | -27.37% |
| Variazione dall'IPO | 16,734.18% |
Notizie e aggiornamenti recenti
531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.Recent updates
531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Interim Dividend And Revised Assumptions Will Support A Balanced Outlook
Analysts have trimmed their price target on Emami from ₹510 to about ₹453, pointing to updated assumptions around a lower future P/E multiple, an adjusted discount rate, and revised expectations for revenue growth and profit margins. What's in the News The board of directors declared a 2nd interim dividend of ₹6 per equity share of face value ₹1 each, described as 600% on 436,500,000 equity shares for the financial year 2025-26 (Key Developments).531162: Second Interim Dividend Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami by about ₹31 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News The board approved a second interim dividend of ₹6 per equity share of ₹1 each, equal to 600% on 436,500,000 equity shares for FY 2025-26, with the record date set for 10 February 2026 and payment scheduled on or before 6 March 2026 (Key Developments).
531162: February Dividend And Board Review Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami to ₹637 from ₹651, citing slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E that point to a marginally more conservative outlook on the stock's valuation. What's in the News A board meeting on 4 February 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 and to consider a 2nd interim dividend for FY 2025-26 (company filing).531162: Interim Dividend And Stable Assumptions Will Support A Balanced Outlook
Analysts have maintained their fair value estimate for Emami at ₹510. They have made only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, which feed into the updated price target rationale.531162: Board Review And Interim Dividend Will Shape A Balanced Outlook
Analysts have trimmed their price target for Emami from ₹540.54 to ₹510.00, citing refreshed assumptions that include slight adjustments to revenue growth, profit margins and the future P/E multiple under a marginally lower discount rate. What's in the News Emami has scheduled a board meeting on Feb 04, 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December, 2025 (Key Developments).531162: February Board Meeting And Dividend Decision Will Reinforce Bullish Outlook
Analysts have trimmed their price target for Emami slightly to ₹651 from about ₹653. The adjustment reflects small tweaks to their fair value, discount rate, revenue growth and profit margin assumptions, alongside a marginally lower expected future P/E multiple.531162: February Dividend Decision Will Support Bullish Long-Term View
Analysts have made only a minor adjustment to their price view on Emami, with the updated fair value at ₹653.25. A slightly lower discount rate, along with revised assumptions for revenue growth, profit margin, and future P/E, serve to fine tune rather than overhaul the prior framework.531162: Upcoming Dividend Decision Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami from ₹883 to ₹807. This reflects slightly lower margin and valuation expectations that more than offset modestly stronger projected revenue growth and a reduced discount rate.531162: Interim Dividend Decision At November Meeting Will Support Bullish Outlook
Analysts have nudged their price target on Emami slightly higher to align with a fair value of ₹653.25. This reflects marginally lower perceived risk and a steady outlook on growth, margins, and future valuation multiples.531162: Board Will Consider Interim Dividend At November 10 Results Meeting
Analysts have revised their price target for Emami down from ₹697.96 to ₹653.25. They cite updated assessments of the company's growth prospects and valuation metrics as reasons for the change.531162: Board To Weigh Interim Dividend At November 10 Meeting
Analysts have slightly revised their price target for Emami downward from ₹706.24 to ₹697.96. This change reflects minor adjustments in growth and profitability expectations.
Relaunching Fair And Handsome And Capitalizing On Dermicool Innovations Will Propel Earnings Growth
Strategic relaunches and product innovations aim to boost revenue, particularly in Fair and Handsome, Kesh King, Dermicool, and BoroPlus Soft segments.Rendimenti per gli azionisti
| 531162 | IN Personal Products | IN Mercato | |
|---|---|---|---|
| 7D | 0.9% | 1.5% | -0.7% |
| 1Y | -33.3% | -11.6% | -4.3% |
Ritorno vs Industria: 531162 ha avuto una performance inferiore rispetto al Indian Personal Products che ha registrato un rendimento -11.6 % nell'ultimo anno.
Rendimento vs Mercato: 531162 ha avuto una performance inferiore al mercato Indian che ha registrato un rendimento -4.3 % nell'ultimo anno.
Volatilità dei prezzi
| 531162 volatility | |
|---|---|
| 531162 Average Weekly Movement | 4.1% |
| Personal Products Industry Average Movement | 4.9% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.7% |
Prezzo delle azioni stabile: 531162 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato Indian.
Volatilità nel tempo: La volatilità settimanale ( 4% ) di 531162 è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1974 | 3,217 | Harsha Agarwal | www.emamiltd.in |
Emami Limited produce e commercializza prodotti per la cura della persona e della salute in India e a livello internazionale. Fornisce crema antisettica ayurvedica, polvere di calore pungente, lozione per il corpo doodh kesar, lozione di aloe neem, vasocare, olio di cocco, gel di aloe vera e prodotti per l'igiene con il marchio Boroplus; olio fresco, extra thanda, olio ayurvedico d'oro, olio ayurvedico per massaggio del corpo e antistress therapy, talco fresco maxx e talco fresco con il marchio Navratna; e balsamo, balsamo ultra-power, roll-on quick relief, olio ortho vedic, unguento, gel e spray relief, prodotti per l'igiene, pancharishta, nityam e kesari jivan con il marchio Zandu. L'azienda offre anche una crema radiante e un lavaggio istantaneo del viso per uomini con il marchio Fair and Handsome; prodotti per la cura dei capelli e shampoo con il marchio Kesh King; balsamo con il marchio Mentho Plus; polvere contro il calore pungente con il marchio Dermicool; olio per capelli, shampoo e balsamo con il marchio Emami 7 Oils in One; deodoranti con il marchio HE; colori per capelli con il marchio Emami Diamond Shine; talco con il marchio Emami Golden Beauty; crema per l'equità a base di erbe con il marchio Emami Naturally Fair; dentifricio con il marchio Ayucare; colori e oli per capelli con il marchio Emami Gold; e creme idratanti, lozioni, creme morbide, creme e oli di glicerina, gelatina di petrolio, shampoo per bambini e altri prodotti per la pelle con il marchio Cream21.
Emami Limited Riepilogo dei fondamenti
| 531162 statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | ₹172.07b |
| Utili (TTM) | ₹7.75b |
| Ricavi(TTM) | ₹37.80b |
531162 è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| 531162 Conto economico (TTM) | |
|---|---|
| Ricavi | ₹37.80b |
| Costo del fatturato | ₹11.38b |
| Profitto lordo | ₹26.42b |
| Altre spese | ₹18.66b |
| Utili | ₹7.75b |
Ultimi utili riportati
Mar 31, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | 17.76 |
| Margine lordo | 69.89% |
| Margine di profitto netto | 20.51% |
| Rapporto debito/patrimonio netto | 4.2% |
Come si è comportato 531162 nel lungo periodo?
Vedi performance storica e confrontoDividendi
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/06/10 19:17 |
| Prezzo dell'azione a fine giornata | 2026/06/10 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2026/03/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Emami Limited è coperta da 43 analisti. 21 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Parin Tanna | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Ajay Thakur | Anand Rathi Shares and Stock Brokers Limited |